| ABPI notes drop in medicine prices | Posted on 17/12/2009 in Pharmaceutical Company Product News The Association of the British Pharmaceutical Industry (ABPI) has announced that the UK has fallen to the bottom of the official league table that compares the price of medicines across Europe.
Citing figures that are published in an annual report to parliament from the Department of Health, the body noted that the UK ranks in 12th place out of 13 different countries.
The study compares the 2008 prices for the leading 150 branded medicines in 11 countries across Europe, as well as Australia and the US.
The UK was ranked below the US and every European country, with only Australia finishing lower in the table.
David Fisher, the ABPI commercial director, said: "What we are talking about here is the breakthrough medicines which make huge differences to people's lives. Prices in the UK are less than in any other comparative European country."
Earlier this month, the ABPI welcomed the proposal for a patent box that would encourage research and development within the UK, which was outlined by the chancellor of the exchequer in the pre-Budget report.Other news stories from 17/12/2009
Read more in the Zenopa News Archive
How this news is generated
|  |
|
